December 2010 Volume 6, Issue 12
Volume 6, Issue 12 | December 2010
December 2010
In this Issue
Global News
MacroGenics hits winning target
Biotech firm’s DART antibody technology nabs potential $2.1 billion deal with Boehringer IngelheimBMS builds bridges
Bristol-Myers Squibb taps Chinese partner to develop early-stage oncology compoundChinese take-out
China CDC signs agreement with Fred Hutchinson Center to address infectious disease and cancer researchA DREAM alliance in pain management
Evotec and Apeiron Biologics build pain alliance around key molecule for pain regulationLicense to research
Compugen licenses novel oncology target to Seattle GeneticsDiagnostics
Yin and yang
GE Healthcare acquires cancer diagnostic company Clarient Inc.A bio duo
bioMérieux and Biocartis sign strategic partnership in flexible molecular diagnosticsTripartite alliance
Quintiles, Dako and AstraZeneca aim to speed development of personalized medicineNo fish story
UK Yorkshire Cancer Research Lab says luminous jellyfish cells help diagnose cancerResearch & Development
Stem cell controversy rages on
Plaintiffs in case assert beliefs about embryonic stem cell research as final briefs are filed in federal lawsuitThe shot(s) heard ’round the world
Hikma expands its global injectables business through the acquisition of Baxter Healthcare’s Multi-Source injectables businessMouse model message
Autism Speaks, SAGE Labs collaborate on plan to develop knockout rat models targeted toward treating autismMaking a splash
Kadmon Pharmaceuticals, a new player in the biopharmaceutical landscape, is making dealsTrue relief with sustained release
SurModics and Edge Therapeutics team up to develop sustained-release, site-specific neurological to fend off complications after subarachnoid hemorrhageQ&A with the stem cell case plaintiffs
Dr. James L. Sherley and Dr. Theresa Deisher share their thoughts about embryonic stem cell research and why they oppose President Obama's order to reinstate federal funding for eSC workCommentary
Publisher’s note: A look at the ddn’s top five stories of 2010
Out of all of our print and online news coverage, we have picked five stories that we feel illustrate some high points and show how ddn is unique in reporting industry newsWhat is analytical chemistry?
We analytical chemists continue to have a variety of concerns about what we do, and those concerns vary with the context of where we do it. The argument stems from confusion over the worthiness of providing a service and whether that can ever fit our definition of science.New generation of sequencing technologies can replace quantitative PCR in mainstream R&D
The most powerful advance in genomics of the last five years has taken place in DNA sequencing technology. Capillary and gel-based Sanger sequencing has been superseded by new massively parallel approaches that offer several orders of magnitude greater sequencing capacity, at >500-fold reduction in cost per base.Special Reports
Financing the fight
Foundations are at ground zero in the battle against cancerPink ribbons and yellow bracelets
The strange paradox of cancer’s persistence in the face of public optimism about progress toward a cureContract Services
Off to the CRO races
Horizon Discovery acquires Hypoxium, launches Horizon Discovery ServicesVenn Life Sciences completes acquisition of DCI France
Addition expands Venn’s clinical trial management services in EuropeEager for the east
HUYA, Quintiles to co-develop new cancer drug sourced in ChinaPPD expands investigator network in India
Large investigator site aims to provide clients with faster patient enrollment and reduced time to approvalFeature
Bringing it together
LabAutomation2011 in Palm Springs will mark the first large gathering of members under the new SLAS bannerInstruments & Informatics
Sequencing evolution
Roche partners with DNA Electronics to develop semiconductor-based sequencing systemImage is everything
PerkinElmer and LinaTech to provide imaging subsystems for cancer treatmentLane to lane, run to run
Caliper turns to Sony Blu-ray technology for expedited microfluidics workflowPortal opens ways for smoother workflows
Perceptive Informatics enhances its eClinical platform with IBM technologiesOmics & Systems Biology
Genomic sequencing gets ready to take off
1000 Genomes Project publishes analysis of pilot-phase work and prepares to launch next steps with help of companies like Affymetrix, Illumina, Life Technologies and 454 Life SciencesA one-in-a-thousand genome
Oppenheimer Foundation to direct sequencing of first human genome in PGP-1K ProjectZeroing in on Huntington’s
Alnylam, Medtronic and CHDI Foundation form collaboration to advance RNAi therapeutic for Huntington’s diseaseBonded by BORG
miRagen Therapeutics signs research, licensing agreements with University of Colorado for microRNA profiling of human heart failureTesting microRNAs on Horizon
Mirna Therapeutics will use Horizon Discovery’s X-MAN models to test activities of its tumor suppressor miRNAs
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
